[Heart transplantation]

Area of Science:

• Cardiology
• Surgical Innovation
• Immunosuppression

Context:

• Clinical heart transplantation began in 1964.
• Standardization by Shumway and introduction of cyclosporine in 1982 significantly increased patient numbers.
• Persistent donor organ shortage limits the number of heart transplants performed annually (3,000-3,500).

Purpose:

• To provide an overview of the historical development and current status of heart transplantation.
• To highlight the impact of immunosuppression on patient numbers and outcomes.
• To address the critical issue of donor organ scarcity in heart transplantation.

Summary:

• Heart transplantation has evolved since its inception in 1964.
• The widespread adoption of standardized surgical techniques and cyclosporine has led to increased transplant activity.
• Despite advancements, the number of heart transplants remains constrained by donor availability, with survival rates of 80% (1-year) and 73% (3-year).

Impact:

• Improved patient survival rates following heart transplantation.
• Ongoing efforts to address donor shortages are crucial for expanding access to this therapy.
• The establishment of heart transplantation programs, such as the one anticipated in Japan, signifies global progress in cardiac surgery.